pexels steve johnson 1530710

Recombinant Portfolio Management — Recognising and Enabling Innovation

Portfolio management has become standard practice in pharmaceutical R&D over the last decade. Most companies have implemented processes and systems with varying degrees of sophistication and rigour across the entire R&D value chain from early discovery to late development, both for internal opportunities and as part of due diligence and licensing activities for external opportunities.

Discover Other Articles

Discover Other Articles